Assessment of HBV and HCV Seroprevalence through Rapid Point-of-Care Testing in Earthquake Survivors in Southeastern Türkiye

1

The 2023 earthquakes in Türkiye affected nine million people, resulting in significant casualties and damage, particularly in the Southeastern Anatolia Region.
2

Türkiye has a moderate HBV seroprevalence of 4%, with the Southeastern Anatolia Region showing the highest rate at 7.3% due to various socio-economic factors.
3

Rapid point-of-care tests were utilized to assess HBV and HCV seroprevalence among earthquake survivors in Diyarbakır, highlighting the need for accessible health screenings.
4

The study included 251 volunteers from container cities, focusing on the prevalence of HBV and HCV infections in a population affected by the recent earthquakes.
5

The use of rapid diagnostic tests is crucial in emergency settings, providing quick and reliable results for screening viral infections in vulnerable populations.

1